絞り込み

16642

広告

The Khorana Score in Predicting Venous Thromboembolism for Patients With Metastatic Urothelial Carcinoma and Variant Histology Treated With Chemotherapy.

著者 Ramos JD , Casey MF , Bamias A , De Giorgi U , Bellmunt J , Harshman LC , Ladoire S , Wong YN , Alva AS , Rosenberg JE , Galsky MD , Yu EY ,
Clin Appl Thromb Hemost.2016 Sep 16 ; ():.
この記事をPubMed上で見るPubMedで表示
この記事をGoogle翻訳上で見る Google翻訳で開く

スターを付ける スターを付ける     (19view , 0users)

Full Text Sources

The Khorana score is a predictive risk model for venous thromboembolism (VTE) in patients with cancer planning to receive chemotherapy. Urothelial carcinoma and variant histologies (UC/VH) were underrepresented in the model. We sought to evaluate whether the Khorana score predicts for VTE in a retrospective multinational data set of patients with metastatic UC/VH.
PMID: 27637910 [PubMed - as supplied by publisher]
印刷用ページを開く Endnote用テキストダウンロード